Showing results (141-150 of 453) with videos related to

Sort By:
Pageof 46
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|May 15, 2016
Phase I Study of the Investigational Anti-Guanylyl Cyclase Antibody-Drug Conjugate TAK-264 (MLN0264) in Adult Patients with Advanced Gastrointestinal MalignanciesKhaldoun Almhanna, Thea Kalebic, Cristina Cruz, et al.
NPJ Precision Oncology|October 27, 2022
Challenges and opportunities associated with the MD Anderson IMPACT2 randomized study in precision oncologyHenry Hiep Vo, Siqing Fu, David S Hong, et al.
JCO Precision Oncology|April 5, 2024
First Use of AXL Targeting in Metastatic, Refractory, Adenoid Cystic Carcinoma: A Case ReportCamilla O Hoff, Eduardo Andreazza Dal Lago, Juliana Mota Siqueira, et al.
Trends in Cancer|June 23, 2021
Development of poly(ADP-ribose) polymerase inhibitor and immunotherapy combinations: progress, pitfalls, and promisesMelissa M Pham, Natalie Y L Ngoi, Guang Peng, et al.
Immunotherapy|September 9, 2020
Cross-neutralization activity against SARS-CoV-2 is present in currently available intravenous immunoglobulinsJosé María Díez, Carolina Romero, Júlia Vergara-Alert, et al.
Emerging Microbes & Infections|November 13, 2019
Blocking transmission of Middle East respiratory syndrome coronavirus (MERS-CoV) in llamas by vaccination with a recombinant spike proteinJordi Rodon, Nisreen M A Okba, Nigeer Te, et al.
Drugs in Context|December 20, 2016
Relative bioavailability of three formulations of galunisertib administered as monotherapy in patients with advanced or metastatic cancerIvelina Gueorguieva, Ann Cleverly, Durisala Desaiah, et al.
Clinical Neurology and Neurosurgery|October 23, 2015
Prognostic implications of epilepsy in glioblastomasManuel Toledo, Silvana Sarria-Estrada, Manuel Quintana, et al.
Cancer Discovery|April 3, 2021
Development of Immunotherapy Combination Strategies in CancerTimothy A Yap, Eileen E Parkes, Weiyi Peng, et al.
Pageof 46